From Harvard Medical School comes the news that the costly advertising of new prescription drugs targeted at the consumer may not have any effect on sales of expensive drugs. Pharmaceutical companies spent about $4.2 billion in direct-to-consumer ads in 2005 yet researchers now report the effect of all that spending may be minimal. A research team set up an experiment using French-speaking Quebec residents as their "control" group.